...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith funding???
5
Jun 15, 2019 01:28PM
4
Jun 15, 2019 07:08PM
4
Jun 15, 2019 09:33PM
4
Jun 16, 2019 07:41AM
3
Jun 16, 2019 12:37PM
3
Jun 17, 2019 01:57PM
3
Jun 17, 2019 04:53PM
2
Jun 17, 2019 05:00PM
2
Jun 18, 2019 12:19PM
2
Jun 24, 2019 01:48PM
3
Jun 24, 2019 04:43PM
6
Jun 25, 2019 12:44AM
4
Jun 25, 2019 10:59AM
7
Jun 25, 2019 11:45AM
4
Jun 25, 2019 12:45PM
4
Jun 25, 2019 01:13PM

Zenith did do a couple of small PP's recently.  One reported on March 25 for about $375k to investors in AB and BC.  The other reported on June 4 for about 67k to a Cayman investor.

You are correct Koo that Zenith pays RVX for some shared lab facilities, I imagine the timing of payments is somewhat flexible.

3
Jun 25, 2019 01:37PM
5
Jun 25, 2019 02:54PM
4
Jun 25, 2019 03:01PM
3
Jun 26, 2019 12:16PM

Jun 26, 2019 01:02PM
3
Jun 26, 2019 02:30PM
Share
New Message
Please login to post a reply